Abbott Labs to pay $160 mln over kickbacks, false diabetes claims to Medicare

Abbott Laboratories (ABT.N) will pay $160 million to resolve claims that two of its units submitted false claims to Medicare by providing kickbacks to diabetes patients, including “free” or “no cost” glucose monitors, the U.S. Department of Justice said. Monday’s settlement resolves claims that Arriva Medical LLC – once the largest Medicare mail-order diabetes testing […]

Continue Reading